XML 87 R76.htm IDEA: XBRL DOCUMENT v3.24.3
Loss Per Common Share - Schedule of Computation of Basic and Diluted Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Earnings Per Share [Abstract]        
Loss before preferred dividends and accretion of Series A Preferred Stock $ (23,137) $ (25,324) $ (38,821) $ (79,629)
Dividends and accretion of Series A Preferred Stock (8,094) (7,872) (24,018) (21,236)
Net loss attributable to common shareholders of Evolent Health, Inc. - basic (31,231) (33,196) (62,839) (100,865)
Net loss attributable to common shareholders of Evolent Health, Inc. - diluted $ (31,231) $ (33,196) $ (62,839) $ (100,865)
Weighted-average common shares outstanding - basic (in shares) 114,862 112,282 114,565 110,464
Weighted-average common shares outstanding - diluted (in shares) 114,862 112,282 114,565 110,464
Basic and diluted:        
Basic (in dollars per share) $ (0.27) $ (0.30) $ (0.55) $ (0.91)
Diluted (in dollars per share) $ (0.27) $ (0.30) $ (0.55) $ (0.91)